Status:
WITHDRAWN
Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France
Lead Sponsor:
AstraZeneca
Conditions:
Self-administered Questionnaire to Patients
Eligibility:
All Genders
60+ years
Brief Summary
The purpose of this study is to assess in general population low-dose aspirin and gastroprotective agent compliance and reasons for bad compliance
Eligibility Criteria
Inclusion
- French people \> 60 years old, part of Kantar Health Access Sant� panel
Exclusion
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
7300 Patients enrolled
Trial Details
Trial ID
NCT01238809
Start Date
June 1 2011
End Date
July 1 2011
Last Update
June 8 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.